---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-005358"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T04:10:08.956672+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# The Joint Corp Q2 revenue rises 24% to $25.1M, net income plunges to $345k from $2.7M

## Summary
- Revenue $25.1M (+24% YoY); net income $345k ($0.02 EPS) vs $2.7M ($0.18) prior year.
- Adjusted EBITDA $2.6M, down from $3.8M; operating income $473k vs $2.0M.
- System-wide sales $106M (+21%); system-wide comp sales +8%; total clinics 769 (+33 net).
- Cash $9.4M at June 30, down from $19.5M at Dec 31 due to clinic acquisitions and greenfields.
- FY 2022 guidance reaffirmed: revenue $98-102M, Adj EBITDA $12-14M, franchised openings 110-130.

## SEC filing metadata
- accession: 0001171843-22-005358
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000117184322005358/0001171843-22-005358-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000117184322005358/f8k_080422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-005358
- JSON: https://secwatch.observer/filing/0001171843-22-005358.json
- Plain text: https://secwatch.observer/filing/0001171843-22-005358.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.